NO954681D0 - Kjemiske forbindelser - Google Patents

Kjemiske forbindelser

Info

Publication number
NO954681D0
NO954681D0 NO954681A NO954681A NO954681D0 NO 954681 D0 NO954681 D0 NO 954681D0 NO 954681 A NO954681 A NO 954681A NO 954681 A NO954681 A NO 954681A NO 954681 D0 NO954681 D0 NO 954681D0
Authority
NO
Norway
Prior art keywords
chemical connections
connections
chemical
Prior art date
Application number
NO954681A
Other languages
English (en)
Norwegian (no)
Other versions
NO954681L (no
Inventor
Peter Clive Cherry
John Derek Cocker
Andrew David Searle
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO954681L publication Critical patent/NO954681L/no
Publication of NO954681D0 publication Critical patent/NO954681D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO954681A 1993-05-21 1995-11-20 Kjemiske forbindelser NO954681D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939310635A GB9310635D0 (en) 1993-05-21 1993-05-21 Chemical compounds
PCT/EP1994/001613 WO1994027989A1 (en) 1993-05-21 1994-05-19 Carbazole derivatives with 17,20-lyase-inhibiting activity

Publications (2)

Publication Number Publication Date
NO954681L NO954681L (no) 1995-11-20
NO954681D0 true NO954681D0 (no) 1995-11-20

Family

ID=10736007

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954681A NO954681D0 (no) 1993-05-21 1995-11-20 Kjemiske forbindelser

Country Status (19)

Country Link
EP (1) EP0699196A1 (cg-RX-API-DMAC10.html)
JP (1) JPH08510455A (cg-RX-API-DMAC10.html)
CN (1) CN1126473A (cg-RX-API-DMAC10.html)
AU (1) AU6928794A (cg-RX-API-DMAC10.html)
BG (1) BG100154A (cg-RX-API-DMAC10.html)
CA (1) CA2162921A1 (cg-RX-API-DMAC10.html)
CZ (1) CZ305195A3 (cg-RX-API-DMAC10.html)
FI (1) FI955587A7 (cg-RX-API-DMAC10.html)
GB (1) GB9310635D0 (cg-RX-API-DMAC10.html)
HU (1) HUT73790A (cg-RX-API-DMAC10.html)
IL (1) IL109703A0 (cg-RX-API-DMAC10.html)
NO (1) NO954681D0 (cg-RX-API-DMAC10.html)
OA (1) OA10195A (cg-RX-API-DMAC10.html)
PE (1) PE31195A1 (cg-RX-API-DMAC10.html)
PL (1) PL311702A1 (cg-RX-API-DMAC10.html)
SK (1) SK142495A3 (cg-RX-API-DMAC10.html)
TW (1) TW279866B (cg-RX-API-DMAC10.html)
WO (1) WO1994027989A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA943494B (cg-RX-API-DMAC10.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960704852A (ko) * 1993-09-30 1996-10-09 오노다 마사요시 아졸 유도체 및 이의 약제학적 조성물 (Azole derivative and pharmaceutical composition thereof)
WO1996014090A1 (en) * 1994-11-07 1996-05-17 Janssen Pharmaceutica N.V. Compositions comprising carbazoles and cyclodextrins
AU702406B2 (en) * 1995-03-01 1999-02-18 Yamanouchi Pharmaceutical Co., Ltd. Imidazole derivatives and medicinal composition thereof
CA2281598A1 (en) * 1997-02-21 1998-08-27 Tetsuya Aono Fused ring compounds, process for producing the same and use thereof
MXPA03004347A (es) 2000-11-17 2004-05-04 Takeda Chemical Industries Ltd Nuevos derivados de imidazol, metodo de produccion y uso de los mismos.
US6960586B2 (en) 2000-11-20 2005-11-01 Takeda Pharmaceutical Company Limited Imidazole derivatives, process for their preparation and their use
EP1348706B1 (en) 2000-12-08 2009-08-19 Takeda Pharmaceutical Company Limited Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof
DK1902026T3 (da) 2005-06-24 2010-04-26 Lilly Co Eli Tetrahydrocarbazol-derivater, der kan anvendes som androgen-receptor-modulatorer (SARM)
US8093279B2 (en) 2005-12-13 2012-01-10 Gillian Reed, legal representative Compound
GB0525323D0 (en) * 2005-12-13 2006-01-18 Sterix Ltd Compound
CN100586932C (zh) * 2007-01-26 2010-02-03 中国医学科学院医药生物技术研究所 抗肿瘤化合物及其制备方法
KR101360725B1 (ko) 2009-06-26 2014-02-07 노파르티스 아게 Cyp17의 억제제로서의 1,3-이치환된 이미다졸리딘-2-온 유도체
AU2011212813B2 (en) 2010-02-04 2014-10-23 Radius Health, Inc. Selective androgen receptor modulators
CA2799183A1 (en) 2010-05-12 2011-11-17 Radius Health, Inc. Therapeutic regimens
US9132105B2 (en) 2010-08-04 2015-09-15 Pellficure Pharmaceuticals, Inc. Treatment of prostate carcinoma
US8946260B2 (en) 2010-09-16 2015-02-03 Novartis Ag 17α-hydroxylase/C17,20-lyase inhibitors
US9133182B2 (en) 2010-09-28 2015-09-15 Radius Health, Inc. Selective androgen receptor modulators
WO2012149413A1 (en) 2011-04-28 2012-11-01 Novartis Ag 17α-HYDROXYLASE/C17,20-LYASE INHIBITORS
US9492460B2 (en) * 2013-02-27 2016-11-15 Bristol-Myers Squibb Company Carbazole compounds useful as bromodomain inhibitors
US20160022606A1 (en) 2013-03-14 2016-01-28 Pellficure Pharmaceuticals Inc. Novel therapy for prostate carcinoma
US9421264B2 (en) 2014-03-28 2016-08-23 Duke University Method of treating cancer using selective estrogen receptor modulators
HRP20251500T1 (hr) 2014-03-28 2026-01-02 Duke University Liječenje raka dojke pozitivnog na receptor estrogena uporabom selektivnih modulatora receptora estrogena
US10093620B2 (en) 2014-09-12 2018-10-09 Pellficure Pharmaceuticals, Inc. Compositions and methods for treatment of prostate carcinoma
ES2913470T3 (es) 2016-06-22 2022-06-02 Ellipses Pharma Ltd Métodos de tratamiento de cáncer de mama AR+
CA3044812A1 (en) 2016-10-24 2018-05-03 Pellficure Pharmaceuticals Inc. Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1,4-dione
AU2018205285C9 (en) 2017-01-05 2024-05-23 Radius Pharmaceuticals, Inc. Polymorphic forms of RAD1901-2HCl

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS229934B2 (en) * 1981-07-07 1984-07-16 Pfizer Production method subst.indolylacryte acid derivative
GB8518743D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds

Also Published As

Publication number Publication date
PL311702A1 (en) 1996-03-04
FI955587A0 (fi) 1995-11-20
TW279866B (cg-RX-API-DMAC10.html) 1996-07-01
PE31195A1 (es) 1995-10-18
CA2162921A1 (en) 1994-12-08
AU6928794A (en) 1994-12-20
ZA943494B (en) 1995-01-23
SK142495A3 (en) 1996-06-05
NO954681L (no) 1995-11-20
WO1994027989A1 (en) 1994-12-08
CZ305195A3 (en) 1996-06-12
IL109703A0 (en) 1994-08-26
HUT73790A (en) 1996-09-30
OA10195A (en) 1996-12-18
GB9310635D0 (en) 1993-07-07
JPH08510455A (ja) 1996-11-05
HU9503321D0 (en) 1996-01-29
FI955587A7 (fi) 1995-11-20
CN1126473A (zh) 1996-07-10
EP0699196A1 (en) 1996-03-06
BG100154A (en) 1996-07-31

Similar Documents

Publication Publication Date Title
NO980154D0 (no) Kjemiske forbindelser
NO954681D0 (no) Kjemiske forbindelser
NO922113D0 (no) Kjemiske forbindelser
DE69400828D1 (de) Motor-Getriebe-Antriebsverbindung
NO951433D0 (no) Kjemiske forbindelser
NO980630D0 (no) Kjemiske forbindelser
NO962264D0 (no) Kjemiske forbindelser
FI935534A7 (fi) Teline
ATA135494A (de) Anschlussgarnitur
FI954399A0 (fi) Kemiallinen prosessi
NO954654D0 (no) Benzimiddazolyl-diazacyklo-oktanforbindelse
FI954400L (fi) Kemiallinen prosessi
NO921004L (no) Kjemiske forbindelser
KR950000463U (ko) 구급약품 케이스
DK85393D0 (da) Kemisk forbindelse
KR940026319U (ko) 에어 브렌더(Air-Blender)
NO964809D0 (no) Kjemiske forbindelser
ITRC930003A0 (it) Ecomat c
MX9200170A (es) Procedimiento quimico
FI992U1 (fi) Postlaoda
FI670U1 (fi) Roekanordning
KR950004400U (ko) 권총의 재치대
BR9301673A (pt) Arturbomba
BR9301237A (pt) Axiostato
KR950000546U (ko) 목마